A
$ Value
$0
Shares
19,306
Price
$0
Filed
Mar 9
Insider
Name
Farrow Jeffrey S
Title
See Remarks
CIK
0001405253
Roles
Officer
Transaction Details
Transaction Date
2026-03-05
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
19,306
Footnotes
25% of the option shares shall vest on March 5, 2027, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service. | Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. | The RSUs will vest in four equal annual installments on March 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service.
Filing Info
Farrow Jeffrey S's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-19 | TARS | ▼ | $146K |
| 2026-03-18 | TARS | ▼ | $147K |
| 2026-03-17 | TARS | ▼ | $147K |
| 2026-03-15 | TARS | M | — |
| 2026-03-15 | TARS | M | $0 |
| 2026-03-15 | TARS | M | $0 |
| 2026-03-05 | TARS | A | $0 |
| 2026-03-05 | TARS | A | $0 |
| 2025-06-17 | TARS | ▼ | $550K |
| 2025-06-16 | TARS | M | — |
Other Insiders at TARS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| PYOTT DAVID E I | — | — | 2026-02-18 |
| LINK WILLIAM J PHD | — | $860K | 2026-03-16 |
|
Farrow Jeffrey S
See Remarks
|
— | $440K | 2026-03-19 |
|
Mottiwala Aziz
Chief Commercial Officer
|
— | $893K | 2026-03-19 |
|
Neervannan Seshadri
Chief Operating Officer
|
— | $1.6M | 2026-03-20 |
|
Azamian Bobak R.
President/CEO and Board Chair
|
— | $2.4M | 2026-03-19 |
|
Whitfield Dianne C.
Chief Human Resources Officer
|
— | $839K | 2026-03-19 |
|
Wahl Bryan
General Counsel
|
— | $850K | 2026-03-19 |
|
Lin Elizabeth Yeu
Chief Medical Officer
|
— | $78K | 2026-03-19 |